A Leader in Immuno-Oncology
Bristol-Myers Squibb is committed to discovering, developing and delivering innovative medicines for the treatment of cancer. Our pipeline in oncology is robust, with several experimental anticancer compounds in development. It is also diverse, reflecting a range of modalities and research programs. One such area is immuno-oncology.
Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. We are at the forefront of this science with several compounds in development that are being investigated for use in a variety of cancers.
Bristol-Myers Squibb has been on the leading edge of cancer treatment and continues to be committed to developing and studying investigational compounds as potential treatment options.
At Bristol-Myers Squibb, we’re driven by one purpose: to help patients overcome serious diseases.
We looking for talented people with R&D, commercial, or biologics experience in immuno-oncology. If that’s you, let’s talk about how we can work together to transform lives.